1. Home
  2. TILE vs HRMY Comparison

TILE vs HRMY Comparison

Compare TILE & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interface Inc.

TILE

Interface Inc.

HOLD

Current Price

$33.08

Market Cap

1.9B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$35.34

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TILE
HRMY
Founded
1973
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TILE
HRMY
Price
$33.08
$35.34
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$36.00
$44.11
AVG Volume (30 Days)
501.3K
910.7K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
0.29%
N/A
EPS Growth
32.43
7.97
EPS
0.40
0.55
Revenue
$1,386,854,000.00
$868,453,000.00
Revenue This Year
$6.72
$19.75
Revenue Next Year
$5.61
$12.88
P/E Ratio
$81.63
$65.09
Revenue Growth
5.41
21.51
52 Week Low
$20.37
$25.52
52 Week High
$36.66
$40.87

Technical Indicators

Market Signals
Indicator
TILE
HRMY
Relative Strength Index (RSI) 51.25 51.31
Support Level $27.15 $35.05
Resistance Level $34.97 $35.47
Average True Range (ATR) 1.14 1.59
MACD -0.25 -0.20
Stochastic Oscillator 48.33 46.08

Price Performance

Historical Comparison
TILE
HRMY

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: